A patient with spondylarthropathy treated with TNF-α inhibitors presenting with clinical findings suspicious of metastatic cancer disease

Rheumatology (Oxford). 2018 Dec 1;57(12):2246-2248. doi: 10.1093/rheumatology/key226.

Authors

Julianne Elvenes¹, Silje Fismen², Gunn Marit Lynghaug³, Gunnstein Bakland¹

Affiliations

¹ Department of Rheumatology, University Hospital of Northern Norway, Tromsoe, Norway.
² Department of Pathology, University Hospital of Northern Norway, Tromsoe, Norway.
³ Department of Dermatology, University Hospital of Northern Norway, Tromsoe, Norway.

PMID: 30137507
DOI: 10.1093/rheumatology/key226

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antirheumatic Agents / adverse effects*
Diagnosis, Differential
Female
Humans
Neoplasms / chemically induced
Neoplasms / diagnosis
Spondylarthropathies / drug therapy*
Syphilis / chemically induced
Syphilis / diagnosis*
Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

Antirheumatic Agents
Tumor Necrosis Factor-alpha